Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Return to: PBR Home | Drug Research
Today in Drug Research

Drug Research

Amgen, Arrowhead to develop gene therapies for cardiovascular disease Amgen said it will acquire a stake in Arrowhead Pharmaceuticals and partner with the company in the development of gene therapies for cardiovascular disease. Drug Research > Drug Discovery & Development > News

Latest Drug Research News by Sector

Select a sector from the list or browse by sector below:

Drug Delivery

PAREXEL agrees to acquire ExecuPharm
PAREXEL International has entered into a definitive agreement to acquire ExecuPharm, a global functional service provider (FSP) serving the biopharmaceutical industry.
Drug Research > Drug Delivery > News
UK’s NICE supports restricted use of Alexion Pharmaceuticals' Strensiq
By PBR Staff Writer
The UK’s National Institute for Health and Care Excellence (NICE) has recommended the use of Alexion Pharmaceuticals’ Strensiq (asfotase alfa) drug to treat rare inherited bone disorder in children.
Drug Research > Drug Delivery > News

Drug Discovery & Development

Amgen, Arrowhead to develop gene therapies for cardiovascular disease
By PBR Staff Writer
Amgen said it will acquire a stake in Arrowhead Pharmaceuticals and partner with the company in the development of gene therapies for cardiovascular disease.
Drug Research > Drug Discovery & Development > News
Boehringer, ViraTherapeutics partner to jointly develop oncolytic virus therapy platform
Boehringer Ingelheim and ViraTherapeutics are collaborating to jointly develop a next generation oncolytic virus therapy platform and to investigate ViraTherapeutics’ lead candidate VSV-GP (Vesicular Stomatitis Virus (VSV) glycoprotein (GP)) alone and in combination with other therapies.
Drug Research > Drug Discovery & Development > News